Cost-Effectiveness of a 10- Versus 13-Valent Pneumococcal Conjugate Vaccine in Denmark and Sweden

This publication has 45 references indexed in Scilit:

• Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme
  Vaccine, 2012
• Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands
  Journal of Infection, 2012
• Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
  The Lancet Infectious Diseases, 2011
• Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination
  Expert Review of Vaccines, 2011
• Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
  The Journal of Infectious Diseases, 2010
• Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
  The Lancet, 2007
• National Impact of Universal Childhood Immunization With Pneumococcal Conjugate Vaccine on Outpatient Medical Care Visits in the United States
  Pediatrics, 2006
• Protective Efficacy of a Second Pneumococcal Conjugate Vaccine against Pneumococcal Acute Otitis Media in Infants and Children: Randomized, Controlled Trial of a 7-Valent Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine in 1666 Children
  Clinical Infectious Diseases, 2003
• Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine
  The Pediatric Infectious Disease Journal, 2001
• Epidemiology of acute suppurative otitis media
  American Journal of Otolaryngology, 1986